Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2024-06-13 00:00:00 ET · period of report 2024-06-11 · accession 0001396814-24-000084 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-13 | 2024-06-11 | PCRX | SLONIN JONATHAN | Chief Medical Off | S - Sale | $28.57 | -5,012 | 44.6K | -10% | -$143.2K | |
| 2024-06-13 | 2024-06-12 | PCRX | SLONIN JONATHAN | Chief Medical Off | A - Grant | $0.00 | +54.3K | 98.9K | +122% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-11 | S | D | 5,012 | $28.57 | 44,569.48 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. |
| 2 | Common | Common Stock | 2024-06-12 | A | A | 54,300 | $0.00 | 98,869.48 | D | — | — | (F2) Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2025, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. |